Sonnet BioTherapeutics Holdings, Inc.

NasdaqCM:SONN Stock Report

Market Cap: US$2.0m

Sonnet BioTherapeutics Holdings Management

Management criteria checks 4/4

Sonnet BioTherapeutics Holdings' CEO is Pankaj Mohan, appointed in Jan 2015, has a tenure of 9.83 years. total yearly compensation is $626.63K, comprised of 86% salary and 14% bonuses, including company stock and options. directly owns 1.2% of the company’s shares, worth $23.71K. The average tenure of the management team and the board of directors is 5 years and 5.1 years respectively.

Key information

Pankaj Mohan

Chief executive officer

US$626.6k

Total compensation

CEO salary percentage86.0%
CEO tenure9.8yrs
CEO ownership1.2%
Management average tenure5yrs
Board average tenure5.1yrs

Recent management updates

Recent updates

Sonnet BioTherapeutics regains compliance with Nasdaq's minimum bid price requirement

Oct 04

Sonnet BioTherapeutics announces 1-for-14 reverse stock split

Sep 16

Sonnet gets clearance to start phase 1b/2a trial of SON-080 in Australia

Jul 22

We're A Little Worried About Sonnet BioTherapeutics Holdings' (NASDAQ:SONN) Cash Burn Rate

Dec 19
We're A Little Worried About Sonnet BioTherapeutics Holdings' (NASDAQ:SONN) Cash Burn Rate

Sonnet Bio issued U.S. patent for its albumin binding technology

Jun 08

Sonnet shares rise after completing licensing agreement with New Life Therapeutics

May 03

Sonnet BioTherapeutics reports FY results

Dec 17

CEO Compensation Analysis

How has Pankaj Mohan's remuneration changed compared to Sonnet BioTherapeutics Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$8m

Mar 31 2024n/an/a

-US$8m

Dec 31 2023n/an/a

-US$14m

Sep 30 2023US$635kUS$539k

-US$19m

Jun 30 2023n/an/a

-US$23m

Mar 31 2023n/an/a

-US$27m

Dec 31 2022n/an/a

-US$29m

Sep 30 2022US$1mUS$560k

-US$30m

Jun 30 2022n/an/a

-US$29m

Mar 31 2022n/an/a

-US$27m

Dec 31 2021n/an/a

-US$25m

Sep 30 2021US$792kUS$512k

-US$25m

Jun 30 2021n/an/a

-US$67m

Mar 31 2021n/an/a

-US$73m

Dec 31 2020n/an/a

-US$69m

Sep 30 2020US$2mUS$490k

-US$66m

Jun 30 2020n/an/a

-US$20m

Mar 31 2020n/an/a

-US$9m

Dec 31 2019n/an/a

-US$7m

Sep 30 2019US$548kUS$368k

-US$5m

Compensation vs Market: Pankaj's total compensation ($USD626.63K) is about average for companies of similar size in the US market ($USD652.28K).

Compensation vs Earnings: Pankaj's compensation has been consistent with company performance over the past year.

CEO

Pankaj Mohan (59 yo)

9.8yrs

Tenure

US$626,626

Compensation

Dr. Pankaj Mohan, Ph.D. founded Sonnet BioTherapeutics Holdings, Inc. in 2015 and has since served as a member of its Board of Directors. Dr. Mohan has been Chairman of Sonnet BioTherapeutics Holdings, Inc...

Leadership Team

NamePositionTenureCompensationOwnership
Pankaj Mohan
Founder9.8yrsUS$626.63k1.2%
$ 23.7k
John Cini
Chief Scientific Officer & Co-Founder9.8yrsUS$419.66k0.035%
$ 691.7
Jay Cross
Chief Financial Officer5.5yrsUS$406.81k0.021%
$ 412.5
Donald Griffith
Financial Controller & Director5.8yrsUS$93.94k0.0089%
$ 176.0
Gael Hedou
Chief Operating Officerno datano datano data
Susan Dexter
Chief Technical Officer4.6yrsno data0.029%
$ 579.4
Richard Kenney
Chief Medical Officer3.6yrsno datano data
Manuel Dafonseca
Head of Clinical Operations3.7yrsno datano data
Stephen McAndrew
Senior Vice President of Business Developmentno datano datano data

5.0yrs

Average Tenure

67.5yo

Average Age

Experienced Management: SONN's management team is seasoned and experienced (5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Pankaj Mohan
Founder9.8yrsUS$626.63k1.2%
$ 23.7k
Donald Griffith
Financial Controller & Director9.6yrsUS$93.94k0.0089%
$ 176.0
Hossein Borghaei
Member of Scientific Advisory Boardno datano datano data
Lori McNeill
Independent Director2.2yrsUS$64.33k0.0032%
$ 63.7
Albert Dyrness
Independent Director5.1yrsUS$59.83k0.025%
$ 497.6
Nailesh Bhatt
Independent Director6.3yrsUS$58.33k0.027%
$ 527.9
Guido Cavaletti
Member of Scientific Advisory Boardno datano datano data
Raghu Rao
Independent Director5yrsUS$120.83k0.30%
$ 6.0k
Jason Bock
Member of Scientific Advisory Boardno datano datano data
Robert Wenham
Member of Scientific Advisory Board2.2yrsno datano data

5.1yrs

Average Tenure

60yo

Average Age

Experienced Board: SONN's board of directors are considered experienced (5.1 years average tenure).